AXS Studio

Aimovig Mechanism of Action Animation 

Prev Next
Previous

AXS Studio Interactive Showreel 2021

medical illustration of Mechanism of action animation (MOA animation) for Amgen and Novartis neuroscience about CGRP inhibitor erenumab (Aimovig) for migraine headache (https://www.scienceofmigraine.com). High-end 3D scientific animation. Molecular animation. Neurology animation. Brain, brainstem, blood brain barrier synapse, neurons. Monoclonal antibody (mAb) animation. Professional and patient education. Pharmaceutical marketing. Top medical animation company, AXS Studio.
Next medical animation of 3D medical animation for professional education and patient education about minimal residual disease (MRD) and clinical outcomes in multiple myeloma (cancer). 3D scientific animation. Amgen oncology. Cell biology animation. Oncology animation. Cancer metastasis. Diagnostic imaging animation. Medical technology animation. Pharmaceutical marketing. Top medical animation company, AXS Studio. https://www.myelomarevealed.com/minimal-residual-disease-in-multiple-myeloma/

Multiple Myeloma MRD Medical Animation

Mechanism of action animation (MOA animation) for Amgen and Novartis neuroscience about CGRP inhibitor erenumab (Aimovig) for migraine headache (https://www.scienceofmigraine.com). High-end 3D scientific animation. Molecular animation. Neurology animation. Brain, brainstem, blood brain barrier synapse, neurons. Monoclonal antibody (mAb) animation. Professional and patient education. Pharmaceutical marketing. Top medical animation company, AXS Studio.

Keywords: Animation, 3D, Professional Education, Biotechnology, Neuroscience, Mechanism of Action (MOA)

AXS Studio